ENDEFR
Home › India › APOTEX PHARMACHEM INDIA PRIVATE LIMITED

APOTEX PHARMACHEM INDIA PRIVATE LIMITED

Private Limited Company (Pvt Ltd) · Bangalore, India · LEI 894500EF6OQ0SUO0AA58
LEI active

Summary

APOTEX PHARMACHEM INDIA PRIVATE LIMITED is registered in India and entered in the “Database of Importer Exporter Code (IEC)” under number 0703021231. Its legal form is Private Limited Company (Pvt Ltd). According to GLEIF, its ultimate parent is APOTEX PHARMACEUTICAL HOLDINGS INC. (Canada), which is also its direct parent. That group has 1 subsidiary with LEIs in 2 countries, 1 of them in India. The LEI was first issued on 2 Jan 2020 and the record was last updated on 19 Nov 2025; the next renewal is due by 2 Jan 2027. AssetCensus found 1 data-quality note for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The ultimate-parent link rests on accounts for the period ending 31 Mar 2023, more than 24 months before this data release. The group may have changed since.

Company details

Legal formPrivate Limited Company (Pvt Ltd)
RegisterDatabase of Importer Exporter Code (IEC) · Register website
Registration number0703021231
Registration authorityDirectorate General of Foreign Trade (DGFT) of the Ministry of Commerce and Industry
JurisdictionIndia
Registered addressPlot No 1A, Bommasandra Ind. Area, 4th Phase, Jigani Link Road,, 560099 Bangalore, India
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)4 Mar 2004
LEI894500EF6OQ0SUO0AA58
LEI statusactive
LEI first issued2 Jan 2020
LEI record last updated19 Nov 2025
Next LEI renewal2 Jan 2027
Corroboration of the LEI recordfully corroborated

Group membership

APOTEX PHARMACEUTICAL HOLDINGS INC. Canada lapsed ultimate parent
APOTEX PHARMACHEM INDIA PRIVATE LIMITED this entity

Relationship to the parent

Direct parentUltimate parent
ParentAPOTEX PHARMACEUTICAL HOLDINGS INC.APOTEX PHARMACEUTICAL HOLDINGS INC.
Accounting period1 Apr 2022 to 31 Mar 20231 Apr 2022 to 31 Mar 2023
Evidenceconsolidated accountsconsolidated accounts
Corroborationfully corroboratedfully corroborated
Accounting standardIFRSIFRS
Consolidation percentage reported to GLEIF99.00%99.00%
Relationship start31 Mar 202331 Mar 2023
Recorded at GLEIF since25 Nov 202225 Nov 2022
Last updated19 Nov 202519 Nov 2025
Record statuscurrentcurrent

History

24 Nov 2022Headquarters address changed
24 Nov 2022Registered address changed